More importantly, we further validated that HNF1A-AS1 knockdown induced the reduction of ENO1 expression was regain via miR-22 inhibition, indicating HNF1A-AS1 could positively regulate ENO1 expression by inhibiting miR-22 expression in GBM. The gene discussed is HNF1A; the disease is glioblastoma.